Print Page

其 他 安 全 警 示

 
The United States: FDA warns consumers to not purchase or use Nose Slap and Soul Slap products marketed for alertness and energy boosting (English only)
 
The US Food and Drug Administration (FDA) is warning consumers to not purchase or use Nose Slap and Soul Slap products, which are unapproved drugs marketed to promote alertness and boost energy.

These products are inhalants and primarily contain ammonia. Inhaling ammonia can quickly lead to eye, nose, and throat irritation; coughing; and airway constriction.

FDA has received reports of adverse events such as shortness of breath, seizures, migraines, vomiting, diarrhea, and fainting from consumers after using the Nose Slap or Soul Slap products. These products may have been purchased online through the Nose Slap website.

On 24 Apr 2023, FDA issued a warning letter to Nose Slap LLC for marketing these unapproved drugs in violation of the Federal Food, Drug, and Cosmetic Act. These products have not been demonstrated to be safe or effective for their intended uses.

Please refer to the following website in FDA for details: http://www.fda.gov/drugs/drug-safety-and-availability/fda-warns-consumers-not-purchase-or-use-nose-slap-and-soul-slap-products-marketed-alertness-and

In Hong Kong, the above products are not registered pharmaceutical products.

Ends/Tuesday, May 2, 2023
Issued at HKT 15:00
 
Related Information:
The United States: FDA warns consumers to not purchase or use unapproved inhalan... 上载于 2024-08-07
 
back